Table 2.
Quantitative analysis in functionally different MNV subgroups (VT cutoff 8.40).
| Quantitative analysis in functionally different MNV subgroups (VT cutoff 8.40) | |||
|---|---|---|---|
| Parameter | MNV Subgroups | Mean ± STD | p |
| Age | Low VT MNV | 78 ± 8 | 0.88 |
| High VT MNV | 78 ± 8 | ||
| Speckled fluorescence (quadrants) | Low VT MNV | 1.05 ± 1.03 | <0.001* |
| High VT MNV | 1.63 ± 0.97 | ||
| Leakage area (μm2) | Low VT MNV | 3.78 ± 3.32 | 0.33 |
| High VT MNV | 4.84 ± 5.38 | ||
| MNV area (μm2) | Low VT MNV | 2.49 ± 2.91 | 0.22 |
| High VT MNV | 3.55 ± 4.13 | ||
| MNV/leakage ratio | Low VT MNV | 0.59 ± 0.31 | <0.001* |
| High VT MNV | 0.88 ± 0.24 | ||
| MNV Type (Type 1/Type 2/Mixed) | Low VT MNV | 22/10/9 | =0.33 |
| High VT MNV | 14/8/3 | ||
| LogMAR BCVA baseline | Low VT MNV | 0.63 ± 0.71 | <0.001* |
| High VT MNV | 0.28 ± 0.25 | ||
| LogMAR BCVA 1-year | Low VT MNV | 0.24 ± 0.24 | <0.001* |
| High VT MNV | 0.43 ± 0.32 | ||
| CMT baseline (μm) | Low VT MNV | 484 ± 88 | <0.001* |
| High VT MNV | 380 ± 127 | ||
| CMT 1-year (μm) | Low VT MNV | 362 ± 77 | 0.03 |
| High VT MNV | 324 ± 70 | ||
| N. Intravitreal injections | Low VT MNV | 7.2 ± 1.5 | <0.001* |
| High VT MNV | 5.2 ± 1.9 | ||
| VT MNV | Low VT MNV | 7.6 ± 0.4 | <0.001* |
| High VT MNV | 9.6 ± 1.4 | ||
| VD SCP | Low VT MNV | 0.37 ± 0.02 | 0.18 |
| High VT MNV | 0.38 ± 0.03 | ||
| VD DCP | Low VT MNV | 0.37 ± 0.02 | <0.001* |
| High VT MNV | 0.34 ± 0.02 | ||
| VD CC | Low VT MNV | 0.45 ± 0.03 | 0.66 |
| High VT MNV | 0.45 ± 0.03 | ||
MNVs were divided in accordance with a VT cutoff value of 8.40.
MNV, macular neovascularization; BCVA, best-corrected visual acuity; CMT, central macular thickness; VT, vessel tortuosity; VD, vessel density; SCP, superficial capillary plexus; DCP, deep capillary plexus; CC, choriocapillaris.
Statistically significant values are marked by asterisks (*).